Addex Pharma unveils new mGlu7 receptor negative allosteric modulators
June 17, 2024
Addex Pharma SA has divulged metabotropic glutamate mGlu7 receptor negative allosteric modulators reported to be useful for the treatment of pain, ear disorders and neurological disorders.